Our #MultipleSclerosis ( #MS ) Research Flagship's Chris and Annie explain why consumer & community involvement #CCI is crucial to improving the quality, relevance and #impact of our #research . To get involved or find out more about CCI at the Flagship visit msresearchflagship.org.au

At our #MultipleSclerosis ( #MS ) Research Flagship, consumer and community involvement ( #CCI ) is crucial to improving the quality, relevance and #impact of our #research . To get involved or find out more about CCI at the Flagship visit msresearchflagship.org.au

Our March MS Research Flagship newsletter📰goes behind the scenes of the Australian #MultipleSclerosis Longitudinal Study, profiles our MS Australia research grant recipients, catches up with a former PhD student at the World Health Organization (WHO) in Zambia + more!
Read here👉bit.ly/MSRF243

At our #MultipleSclerosis ( #MS ) Research Flagship, consumer and community involvement ( #CCI ) is crucial to improving the quality, relevance and impact of our research. To get involved or find out more about CCI at the MS Research Flagship visit msresearchflagship.org.au

The new MS genetics study ‘GEMS’, lead by Menzies Institute for Medical Research, plans to revolutionise diagnosis and treatment, and ultimately, it has #MS prevention in its sights.

#multiplesclerosis #msresearch
bit.ly/432t4Mo

Researchers from Menzies Institute for Medical Research are looking for people living with #MS , as well as people who do not have MS, to help investigate the EBV strain that may play a crucial role in developing MS.

Find out more and take part 👉 bit.ly/3RuYqHU

#msresearch

Since launching in 2019 >43,000 people from 179 countries have enrolled in our MS Research Flagship's Understanding #MultipleSclerosis online course developed in partnership with MS Plus and MS Australia. The next course opens 11 March: enrol today here 👉ms.mooc.utas.edu.au/i/mssm

Understanding #MS from Menzies Institute for Medical Research is a course with positive impacts!

63% of participants use learnings in their everyday lives & 97% say they will share with others.

🗓️ Course opens: 11th March 2024
🕰️ Course duration: 6 weeks

ENROL NOW👉 bit.ly/3tMSqRl

At our #MultipleSclerosis ( #MS ) Research Flagship, consumer and community involvement ( #CCI ) is crucial to improving the quality, relevance and impact of our research. To get involved or find out more about CCI at the MS Research Flagship visit msresearchflagship.org.au

We need your help to benchmark workplace mental health throughout Tasmania! If you are a business leader in any sector or industry we invite you to join an interactive workshop to help shape the 2024 Tasmanian workplace study.

redcap.utas.edu.au/surveys/?s=XNA…

📢 Menzies Institute for Medical Research Understanding MS course is open for enrolment. The course is flexible, FREE and suitable for anyone interested in #MultipleSclerosis . Developed in partnership with MS Plus & MS Australia.

Course starts March 11, enrol today: utas.au/de

Dr alicesaul of our #MultipleSclerosis Research Flagship introduces our Understanding MS FREE online course, developed in partnership with MS Plus and MS Australia. It opens on 11 March and you can enrol now 👉 ms.mooc.utas.edu.au/i/mssm #UnderstandingMS #research #onlinecourse

Congratulations to our #MultipleSclerosis Research Flagship's Dr Zhao, Professor Taylor, Dr Campbell and Professor Palmer on their MSJ paper highlighting how #DMT prescriptions and costs continuously increased over the last decade, particularly for higher efficacy DMTs

Congratulations to our #MultipleSclerosis Research Flagship's Dr Zhao, Professor Taylor, Dr Campbell and Professor Palmer on their IJMSC paper highlighting how #DMT prescriptions and costs continuously increased over the last decade, particularly for higher efficacy DMTs

Want to get active, reduce pollution or try something new in 2024? Jump on board our Get BusActive study and receive up to $100 for taking part.
Find out more here
getbusactive.com.au

Researchers are looking for people with #MS to take part in the TAURUS.2 trial, which assesses the use of magnetic brain stimulation (MBS) to regrow and repair the myelin that has been damaged.

To find out more, visit 👉 bit.ly/48Zcj7B